Document is current
Any future updates will be listed below
-
Authors
Hart, Ailsa https://orcid.org/0000-0002-7141-6076
Miller, Laura https://orcid.org/0000-0001-8802-3554
Büttner, Fionn Cléirigh https://orcid.org/0000-0002-5987-3063
Hamborg, Thomas https://orcid.org/0000-0001-7154-3983
Saxena, Sonia https://orcid.org/0000-0003-3787-2083
Pollok, Richard C. G. https://orcid.org/0000-0001-6452-6763
Stagg, Imogen https://orcid.org/0000-0001-9862-5508
Wileman, Vari https://orcid.org/0000-0002-9673-8047
Aziz, Qasim https://orcid.org/0000-0002-2718-2065
Czuber-Dochan, Wladyslawa https://orcid.org/0000-0002-9889-1248
Dibley, Lesley https://orcid.org/0000-0001-7964-7672
Mihaylova, Borislava https://orcid.org/0000-0002-0951-1304
Moss-Morris, Rona https://orcid.org/0000-0002-2927-3446
Roukas, Chris https://orcid.org/0000-0001-8410-7689
Norton, Christine https://orcid.org/0000-0003-2259-0948
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 17 December 2024
First Online: 31 December 2024
Declarations
:
: Ethics approval was received from North West - Greater Manchester West Research Ethics Committee (Reference no: 18/NW/0613) on 11th October 2018. Informed consent to participate was obtained from all participants either in writing (postal) or online before accessing the online version of the survey. The study conformed to the requirements of the Helsinki declaration and the principles of Good Clinical Practice (GCP).
: Not applicable.
: Ailsa Hart: has served as consultant, advisory board member or speaker for AbbVie, Arena, Atlantic, Bristol-Myers Squibb, Celgene, Celltrion, Falk, Galapogos, Lilly, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the Global Steering Committee for Genentech.Laura Miller: NoneFionn Cléirigh Büttner: None.Thomas Hamborg: NoneSonia Saxena: is an NIHR Senior investigator, funded by the National Institute for Health Research (NIHR) School for Public Health Research Grant Reference Number NIHR 204000 and NIHR Northwest London Applied Research CollaborationRichard Pollok: has served as consultant, advisory board member, speaker and/or received educational grants from Dr Falk, Pharmacosmos, Takeda, Janssen, Napp pharmaceuticals and Ferring pharmaceuticals.Imogen Stagg: NoneVari Wileman: NoneQasim Aziz: Funding as PI from Classado Biosciences Ltd; Takeda Pharmaceuticals and Dr Falk Pharma UK for commercial clinical trials. Wladyslawa Czuber-Dochan: Speaker fees from Dr Falk Pharma and research funding from Bristol Myers Squibb and Crohn’s and Colitis UKLesley Dibley: funding to support research from Takeda, Janssen; speaker fees from Abbvie, Janssen and WedMD. BRUK advisory board. Borislava Mihaylova: None Rona Moss-Morris: NoneChris Roukas: NoneChristine Norton: Speaker fees from: Janssen, WebMD, Medscape, Merck Pharmaceutical; Tillotts Pharma UK. Pfizer advisory board.
